Non-Opiate Analgesic

EndogenX has developed a method for potentiating non-opiate analgesics to provide a greatly enhanced the pain relieving effect. Estimates of the number of people who suffer from chronic pain range from 50 to 100 million people in the U.S., including those afflicted with arthritis, fibromyalgia, back pain, cancer and other painful diseases. The ability to provide sustained pain relief without the side effects, addiction potential, tolerance build-up and risk of abuse of opiate-based drugs presents a significant opportunity for EndogenX. Certain segments of the population cannot use opiate pain relievers including as those with opiate addiction and pediatric pain sufferers. Beyond the treatment of chronic pain, other segments of the pain management market including the treatment of acute pain, and moderate pain present expanded opportunity for the Company's product.

	Research		PreClinical		Clinical		Market
ENDG3010 Non-opiate Analgesic